text
stringlengths
59
1.12k
allow both abortion and infanticide. St. Francis would be appalled at such a concept. Biblical person that he was, he understood that woman and man are God’s supreme masterpieces, made in His image and likeness, unlike the animals. Human beings are given dominion over the rest of creation in Genesis 2 not to exploit ho...
and perfect. God entrusts Adam and Eve not with “the environment,” but with “the Garden” – a place of beauty in which we are made to walk with God. So St. Francis loves the birds, but also presses them into the service of the gospel. He saves the wolf of Gubbio from the wrath of angry townspeople, but rebukes it
for its ferocity and calls men and wolf to live everafter in harmony. And the animals of the nativity scene? They are companions of the infant who is the Word made flesh. So the authentic biblical and Catholic approach to “the environment” is not to see it coldly and scientifically as “the environment.” But rather, in ...
Francis, to approach it as the expression of the Father’s beauty, as the gift of the Father’s love, as an icon, a window to the new creation. Reckless exploitation would never fit with such a vision. But neither would some secular environmentalism. Follow Us - Join us on Facebook Join us on Twitter Dr. Marcellino D’Amb...
where Dr. D will be speaking, a chance to WIN a FREE CD and MORE, CLICK HERE! Personal Prayer: Pathway to Joy Marcellino D'Ambrosio, Ph.D. Everyone knows that personal prayer is important. You can't expect to deepen a relationship with God talking with Him only once a week! But how, in the midst of the busy, noisy life...
lead, can we develop a pattern of daily prayer that really works? And if we are successful in carving out some moments for prayer, what do we do? How should we spend that time in way that would be most fruitful? Dr. Marcellino D'Ambrosio has taught spiritual theology academically, but, more importantly, he's had plenty...
to everyday life. With a family of seven, a business, and a non-profit corporation to run, he knows the challenges that a busy, active life can pose to the Christian who wants to pray. In this talk, he lays down principles and gives practical suggestions on how busy laypeople can develop a prayer life that leads to joy...
transformation. CD - $8.95 The Seven Deadly Sins - 3 CD Set What are the Seven Deadly Sins? There are books written about them and movies made about them, but what are they? From about the fifth century, Christian spiritual writers identified seven patterns of sin that, if not broken, would lead to spiritual death. In ...
Dr. Marcellino D'Ambrosio, we learn the destructive, addictive dynamics of these seven vices and how they infiltrate, and ultimately take over people's lives. Most importantly, we find out how to get free of the chains forged by these sins and the necessary qualities to cultivate to make us immune to them in the future...
"The Talk." It's one of the most daunting prospects parents face. Communicating the richness of Catholic teaching on sexuality in a faithful and effective way can be an overwhelming responsibility. But does it have to be so? In this thoroughly revised version of Beyond the Birds and the Bees, Greg and Lisa Popcak empow...
move well beyond "the Talk" by offering a comprehensive guide to raising sexually whole and holy children. Using the riches of Blessed John Paul II's Theology of the Body, the Popcaks help you safely navigate your children from infancy through the teenage years and beyond. Building Our House on Rock: The Sermon On The ...
ends with the parable of the builders on rock or sand. Doing what Jesus asks results in building a life that endures; not doing it results in disaster. The choice is ours, and it’s a scary one. How can we read these words so that we can know what Jesus meant and do it?
Indonesia is known for being prone to natural disasters of all kinds, ranging from climatic (floods, drought) to geologic (earthquakes, landslides, tsunamis, volcanoes, etc.), biological (avian influenza) to man-made (deforestation,
mining, conflicts). With an already high level of food insecurity, households' vulnerability to shocks is high as the assets and structures of communities are jeopardized by these complex emergencies and
a general lack of disaster risk reduction and management. Over the past five years, more than 1,500,000 people have been directly affected by natural disasters, primarily in West Sumatera, West
Java, Central Java, West Nusa Tenggara, East Nusa Tenggara and Papua. Following the tsunami of 2004, the government of Indonesia has become more aware of the risks, both real and
potential, affecting the provinces, and has taken steps to build the capacity of its staff in disaster risk reduction. Emergency preparedness and response has also become a priority for the
Indonesian Church, specifically the national Caritas office—KARINA—and a growing number of dioceses. Various disasters over the past five years offered opportunities for the dioceses in those areas to contribute to
the disaster responses and increase their response and management capacities. This has provided Catholic Relief Services Indonesia with greater opportunity to work with and support the local Church and other
organizations to improve their capacity in emergency response programming. Latest Stories From Indonesia View all stories »» See all the different ways your support helps people around the world after
disasters strike. »» The latest eruption from Indonesia's Mount Merapi volcano killed 70 people and forced thousands to flee from their homes. »» When Sumatran villagers were left homeless after
of Texas| |People Served:||863 (2012 est.)| Since 1957, Catholic Relief Services has been helping rural communities in Indonesia alleviate human suffering, eradicate poverty and become self-reliant. Over the past five
years, CRS in Indonesia has responded to various disasters and helped more than 60,000 people rebuild their lives. Our response to the West Sumatera earthquake in 2009 through cash grant
for transitional shelter has been widely appreciated by the local government and donor community as the most effective strategy to provide timely, appropriate, accountable and high quality interventions. PartnersKARINA (Caritas
CTComms sends on average 2 million emails monthly on behalf of over 125 different charities and not for profits. Take the complexity of technology and stir in the complexity of the legal system and what do you get? Software licenses! If you've ever attempted to read one you know how true this is, but you have to know a...
about software licensing even if you can't parse all of the fine print. By: Chris Peters March 10, 2009 A software license is an agreement between you and the owner of a program which lets you perform certain activities which would otherwise constitute an infringement under copyright law. The software license usually a...
software and the licensing fees, if any, are sometimes discussed in the licensing agreement, but usually it's described elsewhere. If you read the definitions below and you're still scratching your head, check out Categories of Free and Non-Free Software which includes a helpful diagram. Free vs Proprietary: When you h...
referring to your rights and permissions ("free as in freedom" or "free as in free speech"). In other words, a free software license gives you more rights than a proprietary license. You can usually copy, modify, and redistribute free software without paying a fee or obtaining permission from the developers and distrib...
anything, but that's not always the case – in this instance the word free is making no assertion whatsoever about the price of the software. Proprietary software puts more restrictions and limits on your legal permission to copy, modify, and distribute the program. Free, Open-Source or FOSS? In everyday conversation, t...
and "FOSS (Free and Open-Source Software)." In other words, you'll hear these terms used interchangeably, and the proponents of free software and the supporters of open-source software agree with one another on most issues. However, the official definition of free software differs somewhat from the official definition ...
a short description of the difference, read Live and Let License. For a longer discussion from the "free software" side, read Why Open Source Misses the Point of Free Software. For the "open-source" perspective, read Why Free Software is Too Ambiguous. Public domain and copyleft. These terms refer to different categori...
all the freedoms of a free software license, but adds one restriction. Under a copyleft license, you have to release any modifications under the same terms as the original software. In effect, this blocks companies and developers who want to alter free software and then make their altered version proprietary. In practi...
copylefted. However, technically you can release "free software" that isn't copylefted. For example, if you developed software and released it under a "public domain" license, it would qualify as free software, but it isn't copyleft. In effect, when you release something into the public domain, you give up all copyrigh...
really refer to licensing, and they're confusing in light of the discussion of free software above. Freeware refers to software (usually small utilities at sites such as Tucows.com) that you can download and install without paying. However, you don't have the right to view the source code, and you may not have the righ...
In other words, freeware is proprietary software. Shareware is even more restrictive. In effect, shareware is trial software. You can use it for a limited amount of time (usually 30 or 60 days) and then you're expected to pay to continue using it. End User Licensing Agreement (EULA). When you acquire software yourself,...
directly from the vendor's Web site, you usually have to indicate by clicking a box that you accept the licensing terms. This "click-through" agreement that no one ever reads is commonly known as a EULA. If you negotiate a large purchase of software with a company, and you sign a contract to seal the agreement, that co...
supersedes the EULA. Most major vendors of proprietary software offer some type of bulk purchasing and volume licensing mechanism. The terms vary widely, but if you order enough software to qualify, the benefits in terms of cost and convenience are significant. Also, not-for-profits sometimes qualify for it with very s...
Lower cost. As with most products, software costs less when you buy more of it. Ease of installation. Without volume licenses, you usually have to enter a separate activation code (also known as a product key or license key) for each installed copy of the program. On the other hand, volume licenses provide you with a s...
which makes it much easier to find when you need to reinstall the software. Easier tracking of licenses. Keeping track of how many licenses you own, and how many copies you've actually installed, is a tedious, difficult task. Many volume licensing programs provide an online account which is automatically updated when y...
software. These accounts can also coordinate licensing across multiple offices within your organisation. To learn more about volume licensing from a particular vendor, check out some of the resources below: Qualified not-for-profits and libraries can receive donated volume licenses for Microsoft products through TechSo...
Software Donation Program FAQ. For general information about the volume licensing of Microsoft software, see Volume Licensing Overview. If you get Microsoft software from TechSoup or other software distributors who work with not-for-profits, you may need to go to the eOpen Web site to locate your Volume license keys. F...
the Microsoft eOpen Web Site. Always check TechSoup Stock first to see if there's a volume licensing donation program for the software you're interested in. If TechSoup doesn't offer that product or if you need more copies than you can find at TechSoup, search for "volume licensing not-for-profits software" or just "no...
of Adobe products, qualifying and eligible not-for-profits can obtain four individual products or one copy of Creative Suite 4 through TechSoup. If we're out of stock, or you've used up your annual Adobe donation, you can also check TechSoup's special Adobe donation program and also Adobe Solutions for Nonprofits for o...
A Quick Guide to Discounted Software Programs. Pay close attention to the options and licensing requirements when you acquire server-based software. You might need two different types of license – one for the server software itself, and a set of licenses for all the "clients" accessing the software. Depending on the ve...
to the end users themselves (for example, employees, contractors, clients, and anyone else who uses the software in question) or their computing devices (for example, laptops, desktop computers, smartphones, PDAs, etc.). We'll focus on Microsoft server products, but similar issues can arise with other server applicatio...
are slightly different for each one. Fortunately, there are common license types and licensing structures across different products. In other words, while a User CAL (Client Access License) for Windows Server is distinct from a User CAL for SharePoint Server, the underlying terms and rights are very similar. The TechSo...
describing the differences between products, so we'll focus on the common threads in this article. Moreover, Microsoft often lets you license a single server application in more than one way, depending on the needs of your organisation. This allows you the flexibility to choose the licenses that best reflect your organ...
of money. For example, for Windows Server and other products you can acquire licenses on a per-user basis (for example, User CALs) or per-device basis (for example, Device CALs). The license required to install and run most server applications usually comes bundled with the software itself. So you can install and run m...
as you have the right number of client licenses (see the section below for more on that). However, when you're running certain server products on a computer with multiple processors, you may need to get additional licenses. For example, if you run Windows Server 2008 DataCenter edition on a server with two processors, ...
processor. SQL Server 2008 works the same way. This type of license is referred to as a processor license. Generally you don't need client licenses for any application that's licensed this way. Client Licenses for Internal Users Many Microsoft products, including Windows Server 2003 and Windows Server 2008, require cli...
contractors, volunteers, etc.). On the other hand, SQL Server 2008 and other products don't require any client licenses. Read the product description at CTXchange if you're looking for the details about licensing a particular application. User CALs: User CALs allow each user access to all the instances of a particular ...
use to gain access. In other words, if you run five copies of Windows Server 2008 on five separate servers, you only need one User CAL for each person in your organisation who access those servers (or any software installed on those servers), whether they access a single server, all five servers, or some number in betw...
a single CAL assigned to them can access the server software from as many devices as they want (for example, desktop computers, laptops, smartphones, etc.). User CALs are a popular licensing option. Device CALs: Device CALs allow access to all instances of a particular server application from a single device (for examp...
organisation. Device CALs only make sense when multiple employees use the same computer. For example, in 24-hour call centres different employees on different shifts often use the same machine, so Device CALs make sense in this situation. Choosing a licensing mode for your Windows Server CALs: With Windows Server 2003 ...
User CAL or a Device CAL) in one of two licensing modes: per seat or per server. You make this decision when you're installing your Windows Server products, not when you acquire the CALs. The CALs themselves don't have any mode designation, so you can use either a User CAL or a Device CAL in either mode. Per seat mode
is the default mode, and the one used most frequently. The description of User CALs and Device CALs above describes the typical per seat mode. In "per server" mode, Windows treats each license as a "simultaneous connection." In other words, if you have 40 CALs, Windows will let 40 authenticated users have access. The 4...
However, in per server mode, each CAL is tied to a particular instance of Windows Server, and you have to acquire a new set of licenses for each new server you build that runs Windows. Therefore, per server mode works for some small organisations with one or two servers and limited access requirements. You don't "insta...
you install software. There are ways to automate the tracking of software licenses indirectly, but the server software can't refuse access to a user or device on licensing grounds. The licenses don't leave any "digital footprint" that the server software can read. An exception to this occurs when you license Windows Se...
you have 50 licenses, the 51st authenticated user will be denied access (though anonymous users can still access services). Some key points to remember about client licensing: The licensing scenarios described in this section arise less frequently, and are too complex to cover completely in this article, so they're des...
client licenses for anonymous, unauthenticated external users. In other words, if someone accesses your Web site, and that site runs on Internet Information Server (IIS), Microsoft's Web serving software, you don't need a client license for any of those anonymous users. If you have any authenticated external users who ...
cover their licensing requirements. However, the External Connector License (ECL) is a second option in this scenario. The ECL covers all use by authenticated external users, but it's a lot more expensive than a CAL, so only get one if you'll have a lot of external users. For example, even if you get your licenses thro...
an ECL for Windows Server 2008 has an £76 administrative fee, while a User CAL for Windows Server 2008 carries a £1 admin fee. If only a handful of external users access your Windows servers, you're better off acquiring User CALs. Also, an ECL only applies to external users and devices. In other words, if you have an E...
still have to get a CAL for all employees and contractors. Even though Terminal Services (TS) is built into Windows Server 2003 and 2008, you need to get a separate TS CAL for each client (i.e. each user or each device) that will access Terminal Services in your organisation. This TS license is in addition to your Wind...
Microsoft's System Centre products (a line of enterprise-level administrative software packages) use a special type of license known as a management license (ML). Applications that use this type of licensing include System Center Configuration Manager 2007 and System Center Operations Manager 2007. Any desktop or works...
by one of these applications requires a server management license, and there are two types of server management licenses – standard and enterprise. You need one or the other but not both. There are also special licensing requirements if you're managing virtual instances of Windows operating systems. For more informatio...
Microsoft's white paper on Systems Center licensing. Some Microsoft server products have two client licensing modes, standard and enterprise. As you might imagine, an Enterprise CAL grants access to more advanced features of a product. Furthermore, with some products, such as Microsoft Exchange, the licenses are additi...
CAL in order to access the advanced features. See Exchange Server 2007 Editions and Client Access Licenses for more information. With virtualisation technologies, multiple operating systems can run simultaneously on a single physical server. Every time you install a Microsoft application, whether on a physical hardware...
number of "instances" of particular application that you can run using a single license varies from product to product. For more information see the Volume Licensing Briefs, Microsoft Licensing for Virtualization and the Windows Server Virtualization Calculator. For TechSoup Stock products, see the product description ...
lot of excellent resources to help you understand different scenarios. About the Author: Chris is a former technology writer and technology analyst for TechSoup for Libraries, which aims to provide IT management guidance to libraries. His previous experience includes working at Washington State Library as a technology ...
a technology trainer and tech support analyst. He received his M.L.S. from the University of Michigan in 1997. Originally posted here. Copyright © 2009 CompuMentor. This work is published under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. The latest version of Microsoft Office Professional Plus is...
- Our Story - In Memory Vaccination and Immunotherapy for Alzheimer’s Disease Vaccination against amyloid is a promising approach for the development of Alzheimer’s disease (AD) therapeutics. Approximately half of the investigational new therapeutics in human clinical trials for AD
are active or passive immunotherapeutics. Active vaccination involves the injection of an antigen and relies on the production of antibodies in the vaccinated patient. Four human clinical trials of active vaccination currently are under way. Passive immunization is also a
searching for key words “Alzheimer’s and immunotherapy.” Thinking out of the box The development of vaccinations as a strategy for treating or preventing Alzheimer’s is an example of thinking out of the box. Vaccinations commonly are associated with infectious diseases,
like influenza, small pox and polio, which appear to have little in common with neurodegenerative diseases, like Alzheimer’s. Moreover, the brain is an immunoprivileged site with little access to antibodies, so it seems unlikely antibodies would be protective in the
brain. Researchers were pleasantly surprised when Dale Schenk and co-workers at Elan Inc. reported that vaccination of transgenic mouse models of AD against the amyloid Aß peptide prevented amyloid deposition in young animals and removed pre-existing amyloid deposits in older
animals. Subsequent work showed that immunization against Aß prevented or reversed many other pathological features and prevented cognitive dysfunction in transgenic mice and non-human primates. This vaccine (Elan AN1792) was tested in human clinical trials, where it showed similar beneficial
effects of removing amyloid deposits and slowing cognitive decline in patients with significant levels of anti-Aß antibodies, but the clinical trial was halted because 6 percent of the patients developed meningoencephalitis, an inflammatory side effect. Second-generation vaccines and passive immunization
To circumvent the unwanted inflammatory side effects, second-generation active vaccines have been developed and passive immunization strategies have been explored. The second-generation vaccines use small pieces of the amyloid Aß sequence to avoid activating the T-cells responsible for meningoencephalitis, while
passive immunization bypasses the human immune response by directly supplying antibodies. These newer strategies have shown the same beneficial effects in transgenic mice and passive immunization has shown some promise in a subset of patients in human trials, but they
have raised new questions about their effectiveness and potential new side effects. Elan/Wyeth reported preliminary results from clinical trials of their monoclonal antibody, Bapineuzimab, that demonstrated only a small benefit in a subgroup of patients who lack the apoE4 genotype.
They also failed to observe an improved benefit with an increased dose of antibody and reported side effects, like a buildup of fluid in the brain. Results of active vaccination human clinical trials with second-generation vaccines remain to be reported.
Third-generation vaccines and antibodies: Thinking perpendicular to the box Both second-generation vaccines and antibodies suffer from a common problem. They both target linear amino acid sequences found in normal human proteins (the amyloid precursor protein) and in the amyloid deposits
themselves. Making antibodies against normal human proteins can cause autoimmune side effects, in which the immune system is attacking normal human cells in addition to the Alzheimer’s pathology. Fortunately, it is difficult to make antibodies against self-proteins because of immune
suppression of auto antibodies. Third-generation vaccines seek to overcome these problems of autoimmune side effects and autoimmune suppression by using antibodies that target structures specific to the amyloid aggregates and that do not react with normal human proteins. Cure Alzheimer’s
Fund has been supporting two projects that seek to develop third-generation immunotherapeutics. Dr. Charles Glabe’s laboratory is developing active vaccines and monoclonal antibodies that recognize conformations of the amyloid peptide that only occur in the pathological amyloid oligomer aggregates, while
Dr. Rob Moir’s lab is working on cross-linked amyloid peptides (CAPs) that are only found in disease-related aggregates. Dr. Glabe’s strategy relies on the fact that when the Aß peptide aggregates into ß-sheet oligomers, it creates new antibody recognition sites,
known as epitopes, that are not found on native proteins. The surprising finding is that these oligomer-specific antibodies recognize amyloid oligomers from other diseases that involve amyloids formed from sequences unrelated to Aß. This means the same antibodies also may
be effective for other amyloid-related neurodegenerative diseases, like Parkinson’s disease. The explanation for why the antibodies are specific for amyloid oligomers that involve several individual peptide strands arranged in a sheet and yet recognize these sheets when they are formed
from other amino acid sequences is simple and elegant (Figure 1). It is now known that most pathological amyloids aggregate into simple and very regular structures where the peptide strands are arranged in parallel and where the amino acid sequence
is in exact register. This is like a sheet of paper upon which the same sentence is written on each line. The individual amino acids line up and down the sheet in homogeneous tracts, known as “steric zippers.” The steric
zippers do not occur in normal protein structures and the oligomer-specific antibodies are thought to recognize these steric zipper patterns on the surface of the sheets. Since all proteins are made up using the same 20 amino acids, any sequence
in this parallel, in-register structure gives rise to the same steric zippers regardless of the linear sequence, which can explain why the antibodies recognize the oligomers formed by different proteins. Dr. Moir’s group is working on CAPs, where Aß is
cross-linked by oxidation of a tyrosine residue at position 10 of the peptides’ sequence. Aß is oxidized after it is produced from the amyloid precursor protein as a consequence of the abnormally high level of oxidative activity in a brain
with AD and the peptides’ propensity to bind redox active metals. Excessive CAPs generation is associated with the disease state and is not a normal feature of Aß biology. The cross-linking at tyrosine 10 that gives rise to CAPs may
serve to align the peptides in a parallel, in-register fashion and promote the generation of still-larger oligomeric aggregates that display steric zippers on their surface. Dr. Moir and Dr. Rudy Tanzi’s labs found that natural antibodies to CAPs are reduced
in the blood of patients with AD. More recently, evidence published by Tony Weiss-Coray’s group at Stanford University supports the idea that antibodies that recognize steric zippers and CAPs may be important for protecting against Alzheimer’s disease. The levels of
these antibodies that target the zippers and CAPs were among the highest in young, normal humans; levels dropped with aging and with AD. Furthermore, the results of a recent study supported by Baxter Biosciences of patients that received human antibodies
purified from normal individuals (IVIg) reported that antibody treatment reduced the risk of being diagnosed with AD by 42 percent over the five-year study period. This is one of the most remarkable reports of prevention of AD by any therapy.
Although the normal human antibodies that target amyloid primarily recognize the steric zippers and CAPs, these antibodies are present at relatively low levels. It is reasonable to imagine that an even greater protective effect might be achieved by boosting the
levels of these protective antibodies by either active vaccination or passive immunization. Figure 1 shows how the same steric zipper patterns are formed on parallel, in-register oligomers from completely different sequences. A segment of the Aß sequences is shown in